Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/23/2014 09/24/2014 09/25/2014 09/26/2014 09/29/2014 Date
30.69(c) 30.87(c) 30.39(c) 31.03(c) 30.44(c) Last
2 601 468 3 642 954 1 999 437 1 554 004 1 106 966 Volume
-1.57% +0.59% -1.55% +2.11% -1.90% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
11/05Earnings Release
Surperformance© rating of Auxilium Pharmaceuticals,
Trading Rating : Investor Rating :
More about the company
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 383 M
EBIT 2014 6,18 M
Net income 2014 -101 M
Debt 2014 464 M
Yield 2014 -
Sales 2015 476 M
EBIT 2015 115 M
Net income 2015 41,6 M
Debt 2015 427 M
Yield 2015 -
PER 2014 -
PER 2015 62,38
EV / Sales 2014 5,21x
EV / Sales 2015 4,12x
Capitalization 1 533 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
2d ago VIVUS : FDA Approves Stendra sNDA
6d ago AUXILIUM PHARMACEUTICALS : Endo Delivers A Proposal To Acquire Auxilium Pharmace..
6d ago AUXILIUM PHARMACEUTICALS : Responds To Unsolicited Proposal From Endo Internatio..
6d ago AUXILIUM PHARMACEUTICALS : Presents XIAFLEX CCH Data From MULTICORD And Retreatm..
6d ago VIVUS : And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First An..
7d ago Pending 'inversions' that new U.S. Treasury rules may hit
09/23 VIVUS : FDA Approves Stendra sNDA
09/22 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial..
09/22 AUXILIUM PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form..
09/22 AUXILIUM PHARMACEUTICALS : Endo International Comments On Auxilium Pharmaceutica..
09/22 AUXILIUM PHARMACEUTICALS : Licensing Agreements, Results of Clinical Trials, and..
09/22 AUXILIUM PHARMACEUTICALS : Provides Transaction Update
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF